Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Interest Expenses (2018 - 2025)

Historic Interest Expenses for Puma Biotechnology (PBYI) over the last 8 years, with Q3 2025 value amounting to $1.5 million.

  • Puma Biotechnology's Interest Expenses fell 5196.77% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year decrease of 3838.45%. This contributed to the annual value of $12.5 million for FY2024, which is 658.66% down from last year.
  • According to the latest figures from Q3 2025, Puma Biotechnology's Interest Expenses is $1.5 million, which was down 5196.77% from $1.8 million recorded in Q2 2025.
  • Puma Biotechnology's 5-year Interest Expenses high stood at $3.5 million for Q2 2021, and its period low was $1.5 million during Q3 2025.
  • For the 5-year period, Puma Biotechnology's Interest Expenses averaged around $2.9 million, with its median value being $3.1 million (2021).
  • Per our database at Business Quant, Puma Biotechnology's Interest Expenses surged by 2432.43% in 2023 and then plummeted by 5196.77% in 2025.
  • Puma Biotechnology's Interest Expenses (Quarter) stood at $2.7 million in 2021, then grew by 20.64% to $3.3 million in 2022, then grew by 2.29% to $3.4 million in 2023, then decreased by 21.85% to $2.6 million in 2024, then plummeted by 43.19% to $1.5 million in 2025.
  • Its Interest Expenses was $1.5 million in Q3 2025, compared to $1.8 million in Q2 2025 and $2.2 million in Q1 2025.